Pharmaceuticals

Global Plasma Protein Therapeutics Market Analysis For 2026–2030 With Strategic Insights

May 4, 2026May 4, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Does The Market Size Of The Plasma Protein Therapeutics Market Compare Between 2026 And 2030?

The plasma protein therapeutics market has robustly expanded in recent years. Forecasts indicate it will enlarge from $34.68 billion in 2025 to reach $37.09 billion in 2026, registering a compound annual growth rate (CAGR) of 6.9%. The historical expansion of this market stems from several factors, including the increasing prevalence of primary immunodeficiency disorder, rising demand for immunoglobulin therapies, limited plasma donation infrastructure, advancements in protein purification technologies, and regulatory approvals for plasma-derived therapies.

The plasma protein therapeutics market size is anticipated to undergo significant growth in the coming years, with expectations to reach $48.98 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.2%. This projected expansion during the forecast period is primarily attributed to the rise in recombinant albumin and coagulation factors, the increasing availability of subcutaneous administration methods, growing healthcare expenditure in emerging economies, technological innovations within precision medicine, and an uptick in public-private collaborations for plasma collection. Prominent trends throughout this period are expected to include the development of personalized plasma protein therapies, an increase in recombinant protein production, wider acceptance of subcutaneous administration, rising awareness of rare blood disorders, and improved supply chain along with cold chain logistics.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9213&type=smp

Which Strong Drivers Are Impacting The Plasma Protein Therapeutics Market Growth?

The increasing incidence of autoimmune disorders is projected to fuel the expansion of the plasma protein therapeutics market. An autoimmune disorder manifests when the body’s immune system erroneously attacks and destroys its own healthy cells. Therapeutic plasma exchange is employed to treat these autoimmune conditions, which arise when the body misidentifies a part of itself as alien and generates proteins known as autoantibodies to attack that misidentified component. For instance, in May 2023, a study conducted by the University of Glasgow, a UK-based public university, involving 22 million people, determined that autoimmune disorders affect about 10% of the UK’s population, exceeding earlier estimates from 2022. This increasing prevalence of autoimmune disorders is, therefore, driving the growth of the plasma protein therapeutics market going forward.

How Is The Plasma Protein Therapeutics Market Broken Down By Segment Categories?

The plasma protein therapeutics market covered in this report is segmented –

1) By Product: Immunoglobulin, Albumin, Coagulation Factor, C1-esterase Inhibitors, Other Products

2) By Route Of Administration: Intravenous, Subcutaneous

3) By Applications: Primary Immunodeficiency Disorder (PID), Idiopathic Thrombocytopenic Purpura, Secondary Immunodeficiency, Hereditary Angioedema, Other Applications

Subsegments:

1) By Immunoglobulin: Intravenous Immunoglobulin (IVIG), Subcutaneous Immunoglobulin (SCIG)

2) By Albumin: Human Serum Albumin, Recombinant Albumin

3) By Coagulation Factor: Factor VIII, Factor IX, Prothrombin Complex Concentrates

4) By C1-Esterase Inhibitors: Human C1-Esterase Inhibitors, Recombinant C1-Esterase Inhibitors

5) By Other Products: Fibrinogen, Alpha-1 Antitrypsin, Clotting Factor Concentrates

Which Trends Are Shaping Growth In The Plasma Protein Therapeutics Market?

Leading companies operating within the plasma protein therapeutics market are focusing on developing innovative solutions, such as lyophilized plasma formulations, to satisfy the growing demand for portable, stable, and rapidly usable blood products in emergency and pre-hospital care settings. Lyophilized plasma products are freeze-dried formulations that provide an extended shelf life, simpler storage, and quicker reconstitution when compared to traditional frozen plasma, rendering them highly appropriate for trauma, emergency medicine, and field environments. For instance, in October 2023, Octapharma AG, a pharmaceutical company based in Switzerland, secured approval from European medical authorities for the lyophilized version of its octaplasLG product. This advanced formulation allows for convenient pre-hospital transfusion, offering rapid availability, simplified handling, and enhanced stability for critical care situations. The product supports the effective management of trauma and bleeding emergencies, showcasing Octapharma’s dedication to advancing patient care through innovative plasma-based therapies.

Which Players Are Present In The Plasma Protein Therapeutics Market Space?

Major companies operating in the plasma protein therapeutics market are CSL Behring LLC, Grifols SA, China Biologic Products Holdings Inc., Takeda Pharmaceutical Company Limited, Baxter International Inc., Kedrion SpA, LFB SA, Emergent BioSolutions Inc., Reliance Life Sciences Private Limited, ADMA Biologics Inc., Prothya Biosolutions BV, Bio Products Laboratory Ltd., Biotest AG, Taibang Biological Group Co Ltd, Octapharma Plasma Inc., Green Cross Corporation, China National Biotec Group Company Limited, Kamada Ltd., Shire PLC, Octapharma AG

Get The Full Plasma Protein Therapeutics Market Report:

https://www.thebusinessresearchcompany.com/report/plasma-protein-therapeutics-global-market-report

Which Region Dominates The Plasma Protein Therapeutics Market By Market Share?

North America was the largest region in the plasma protein therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plasma protein therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Plasma Protein Therapeutics Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/plasma-protein-therapeutics-global-market-report

Browse Through More Reports Similar to the Global Plasma Protein Therapeutics Market 2026, By The Business Research Company

Plasma Protein Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/plasma-protein-therapeutics-global-market-report

Therapeutic Plasma Exchange Market Report 2026

https://www.thebusinessresearchcompany.com/report/therapeutic-plasma-exchange-global-market-report

Peptide Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/peptide-therapeutics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795